C12Y 207/07083
Udp-n-acetylgalactosamine diphosphorylase
Official title: UDP-N-acetylgalactosamine diphosphorylase (2.7.7.83)
C12Y207/07083 (Udp-n-acetylgalactosamine diphosphorylase) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 3
- Assignees
- 2
- Inventors
- 5
- Latest grant
- 28 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of synthesis of testosteronan polymer and derivatives and uses thereof10 Sep 2026US 2026/0265803 A1Weka Biosciences, LLC
- Use of uap inhibitors to inhibit flux through the hexosamine biosynthetic pathway2 Sep 2021US 2021/0269468 A1The Johns Hopkins University
- Use of uap inhibitors to inhibit flux through the hexosamine biosynthetic pathway31 May 2018US 2018/0148468 A1The Johns Hopkins University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.